Programs

  • Program 1 [2020]

    Received $9.2M from California Health Facilities Financing Authority for Kern Medical Pediatrics inpatient and outpatient renovation and equipmentCalMedForce awarded Kern Medical, on behalf of Kern Medical Foundation, with $1.5M in funding to support Residency Programs (Internal Medicine, OBGYN, Emergency Medicine) supports medical education, training and developmentReceived $600,000 from the State of California to support our Internal Medicine Residency Program and help increase primary care education and training in areas of unmet need throughout CaliforniaKern Medical Foundation began efforts to launch Trauma Informed Care training for our providers through funding received from the State of California in the amount of $50,000Received $100,000 in funding from HealthNet to help expand our telehealth services to support COVID-19 effortsReceived $492,000 to help develop and establish a comprehensive Sickle Cell Clinic at Kern MedicalReceived $12,000 in funding from OSHPD to expand our Health Career Pipeline Program for high school studentsBegan efforts to launch Womens Heart Health Center and raised $15,000 to formalize our effortsEstablished the Kern Medical COVID Relief Fund to help donate over 500 homemade masks to our staff, and meals to various departments throughout Kern Medical to show appreciation for their hard work during such trying timesExpanded our Reach Out and Read program to our second outpatient Pediatrics location which incorporates books into pediatric care by gifting book at each well child visit, encouraging families to read aloud togetherKern Medical Foundation secured funding to help build Kern Medicals Simulation Center, which opened in the summer of 2020. The Simulation Center provides training for medical students, residents, faculty and all clinical staff using the latest technologyThe Valley Fever Institute opened in the summer of 2020The Valley Fever Institute launched an Occupational Training Education Program funded by the Department of Labor. In addition, the Valley Fever Institute entered into a 5-year Cooperative Agreement with the Centers for Disease Control to prevent and control Valley Fever. Year 1 efforts included a physician education series called the Triple Threat: educational series on the prevention, diagnosis and treatment of Valley Fever, COVID-19 and Flu
    Geographies
    Not indicated
    Dates
    Jan 1, 2020 – Dec 31, 2020
    Source
    990
    No causes provided
    No populations provided
    –
    $2.1M

  • Kern Medical Foundation Health Initiatives

    KERN MEDICAL FOUNDATION CONTINUES TO STEWARD FUNDS FROM THE $9.2M RECEIVED FROM CALIFORNIA HEALTH FACILITIES AUTHORITY FOR KERN MEDICAL PEDIATRICS INPATIENT AND OUTPATIENT RENOVATION.KERN MEDICAL FOUNDATION, ON BEHALF OF KERN MEDICAL, WAS AWARDED $46,000 FOR EQUITY AND PRACTICE TRANSFORMATION FROM THE DEPARTMENT OF HEALTH CARE SERVICES.AMERICAN CANCER SOCIETY AWARDED $10,000 TO KERN MEDICAL FOUNDATION TO HELP SUPPORT KERN MEDICAL ONCOLOGY PATIENTS AND PROVIDE TRANSPORTATION AND LODGING ASSISTANCE TO PATIENTS WITH NEEDS.KERN MEDIAL FOUNDATION RECEIVED $120,000 FROM CA BRIDGE PROGRAM TO SUPPORT SUBSTANCE USE AND MAT NAVIGATION SERVICES TO PATIENTS IN THE EMERGENCY DEPARTMENT AT KERN MEDICAL.KERN MEDICAL FOUNDATION, ON BEHALF OF KERN MEDICAL, WAS AWARDED $3M FROM KERN HEALTH SYSTEMS TO SUPPORT PROVIDER RECRUITMENT AND RETENTION, HEALTHCARE WORKFORCE EXPANSION AND QUALITY GRANT PROGRAM THAT WILL ENHANCE THE QUALITY OF CARE DELIVERED TO MEMBERS WITH THE GOAL OF INCREASING PREVENTATIVE HEALTH SERVICES AND CLOSING GAPS IN CARE. KERN MEDICAL FOUNDATION CONTINUED TO RECEIVE $200,000 FROM THE CDC FOR VALEY FEVER EDUCATION AND AWARENESS THROUGH OUR COOPERATIVE AGREEMENT; IMPROVING CLINICAL AND PUBLIC HEALTH OUTCOMES THROUGH NATIONAL PARTNERSHIPS TO PREVENT AND CONTROL EMERGING AND RE-EMERGING INFECTIOUS DISEASE THREATS.KERN MEDICAL FOUNDATION, ON BEHALF OF THE VALLEY FEVER INSTITUTE AT KERN MEDICAL, WAS AWARDED A SUBAWARD AGREEMENT UNDER A U19 RESEARCH GRANT WITH UCLA. ENROLLMENT IN HOST IMMUNOGENETICS AND FUNGAL VIRULENCE MECHANISMS IN COCCIDIOIDOMYCOSIS STARTED IN 2022 AND WILL CONTINUE THROUGH 2027.KERN MEDICAL FOUNDATION, ON BEHALF OF THE VALLEY FEVER INSTITUTE AT KERN MEDICAL, WAS AWARDED A SUBAWARD AGREEMENT WITH UC DAVIS TO FOR A RETROSPECTIVE STUDY OF PATIENTS TREATED WITH CRESEMBA FOR VALLEY FEVER.KERN MEDICAL FOUNDATION, ON BEHALF OF THE VALLEY FEVER INSTITUTE AT KERN MEDICAL, ENROLLED IN A CLINICAL TRIAL OF A NOVEL ANTIFUNGAL; OLOROFIM FOR TREATMENT OF INVASIVE FUNGAL INFECTIONS (IFI) DUE TO MOULDS IN PATIENTS WITH LIMITED OR NO TREATMENT OPTIONS: INTERIM RESULTS FROM A PHASE 2B OPEN-LABEL STUDY (NCT03583164, STUDY 32).KERN MEDICAL FOUNDATION, ON BEHALF OF THE VALLEY FEVER INSTITUTE AT KERN MEDICAL, CONTINUED TO PROVIDE ADMINISTRATIVE OVERSIGHT FOR AN NIH RESEARCH STUDY; AN OBSERVATIONAL STUDY TO ASSESS THE PREVALENCE AND OUTCOMES OF PRIMARY PULMONARY COCCIDIOIDOMYCOSIS (SANDS-PPC).KERN MEDICAL FOUNDATION, ON BEHALF OF THE VALLEY FEVER INSTITUTE AT KERN MEDICAL, SOLICITED AND WAS AWARDED A CONTRACT WITH THE CDC TO PROVIDE SERUM SPECIMENS FROM VALLEY FEVER PATIENTS FOR A BIOBANK.
    Geographies
    Not indicated
    Dates
    Jan 1, 2023 – Dec 31, 2023
    Source
    990
    No causes provided
    No populations provided
    –
    $299.4K